DOI: 10.1111/ijd.70630 ISSN: 0011-9059
Rethinking Corticosteroids in the Kligman–Willis Formula for Melasma
Marina Landau, Jane M. Grant‐Kels, Fotini Bageorgou, Rashmi Sarkar, Mohamad GoldustABSTRACT
Melasma necessitates effective long‐term management that goes beyond initial treatment. Although the Kligman–Willis triple combination is the standard induction therapy, prolonged use of corticosteroids raises safety concerns. We propose a maintenance strategy that spares corticosteroids while still utilizing a formulation that has been proven over the years to be the most effective for treating melasma. This approach aims to enhance safety by omitting corticosteroids.